# Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis

> **NCT00432484** · PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 70 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Lingzhi and Sen Miao San

## Key facts

- **NCT ID:** NCT00432484
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2008-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432484, "Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00432484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*